59 Bronchopulmonary dysplasia, IGF-I & nutrition 3 References 1. Jobe AH. Mechanisms of Lung Injury and Bronchopulmonary Dysplasia. American journal of perinatology 2016;33(11):1076-8. doi: 10.1055/s-0036-1586107 [published Online First: 2016/09/08] 2. Shahzad T, Radajewski S, Chao CM, et al. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Molecular and cellular pediatrics 2016;3(1):23. doi: 10.1186/s40348-016-0051-9 [published Online First: 2016/07/01] 3. Thekkeveedu RK, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology. Respiratory medicine 2017;132:170-77. 4. Mandell EW, Kratimenos P, Abman SH, et al. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol 2019;46(2):291-310. doi: 10.1016/j.clp.2019.02.011 [published Online First: 2019/04/24] 5. Wang J, Dong W. Oxidative stress and bronchopulmonary dysplasia. Gene 2018;678:177-83. doi: 10.1016/j.gene.2018.08.031 [published Online First: 2018/08/12] 6. Rowland KJ, Choi PM, Warner BW. The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg 2013;22(2):101-11. doi: 10.1053/j. sempedsurg.2013.01.007 7. Xu L, Zhang W, Sun R, et al. IGF-1 may predict the severity and outcome of patients with sepsis and be associated with microRNA-1 level changes. Experimental and therapeutic medicine 2017;14(1):797-804. 8. Tanner SM, Berryhill TF, Ellenburg JL, et al. Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol 2015;185(1):4-16. doi: 10.1016/j.ajpath.2014.08.028 9. Ley D, Hallberg B, Hansen-Pupp I, et al. rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial. J Pediatr 2019;206:56-65 e8. doi: 10.1016/j.jpeds.2018.10.033 [published Online First: 2018/11/26] 10. Engstrom E, Niklasson A, Wikland KA, et al. The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res 2005;57(4):605-10. doi: 10.1203/01.PDR.0000155950.67503.BC [publishedOnline First: 2005/02/08] 11. Price WA, Lee E, Maynor A, et al. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia. J Pediatr Gastroenterol Nutr 2001;32(5):542-9. doi: 10.1097/00005176-200105000-00010 [published Online First: 2001/06/29] 12. Yumani DF, Lafeber HN, van Weissenbruch M. Study protocol Nutrition in relation to the endocrine regulation of preterm growth 2015 [updated 14-04-2019. Available from: https:// www.trialregister.nl/trial/5171 accessed 17-12-2021. 13. Jensen EA, Dysart K, Gantz MG, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. Am J Respir Crit Care Med 2019;200(6):751-59. doi: 10.1164/rccm.201812-2348OC [published Online First: 2019/04/18] 14. Yumani DFJ, Calor AK, van Weissenbruch MM. The Course Of IGF-1 Levels and Nutrient Intake in Extremely and Very Preterm Infants During Hospitalisation. Nutrients 2020;12(3) doi: 10.3390/ nu12030675 [published Online First: 2020/03/07] 15. de Waard M, Mank E, van Dijk K, et al. Holder-Pasteurized Human Donor Milk: How Long Can It Be Preserved? J Pediatr Gastroenterol Nutr 2018;66(3):479-83. doi: 10.1097/ MPG.0000000000001782 [published Online First: 2017/10/12] 16. Lofqvist C, Hellgren G, Niklasson A, et al. Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD). Acta paediatrica (Oslo, Norway : 1992) 2012;101(12):1211-6. doi: 10.1111/j.1651-2227.2012.02826.x [published Online First: 2012/08/29] 17. Hellstrom A, Engstrom E, Hard AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112(5):1016-20. [published Online First: 2003/11/05]
RkJQdWJsaXNoZXIy MTk4NDMw